Erratum: Expression of the CTLA-4 ligand CD86 on plasmacytoid dendritic cells (pDC) predicts risk of disease recurrence after treatment discontinuation in CML (Leukemia, (2017), 31, 4, (829-836), 10.1038/leu.2017.9)

C. Schütz; S. Inselmann; S. Saussele; C. T. Dietz; M. C. Müller; E. Eigendorff; C. A. Brendel; S. K. Metzelder; T. H. Brümmendorf; C. Waller; J. Dengler; M. E. Goebeler; R. Herbst; G. Freunek; S. Hanzel; T. Illmer; Y. Wang; T. Lange; F. Finkernagel; R. Hehlmann; M. Huber; A. Neubauer; A. Hochhaus; J. Guilhot; F. X. Mahon; M. Pfirrmann; A. Burchert

ArticleOPEN ACCESS

Erratum: Expression of the CTLA-4 ligand CD86 on plasmacytoid dendritic cells (pDC) predicts risk of disease recurrence after treatment discontinuation in CML (Leukemia, (2017), 31, 4, (829-836), 10.1038/leu.2017.9)

Leukemia

DOI: 10.1038/leu.2017.348

2Citations

9Readers

Abstract

Correction to: Leukemia (2017) 31, 829–836. doi: 10.1038/leu.2017.9; Published online 11 January 2017 Following the publication of this article, the authors noted that family name of Susanne Sausselele was misspelled. The correct spelling is Susanne Saussele. Moreover, the correct name of Dr Mahon is FX Mahon, not F Xavier Mahon.

Cite

CITATION STYLE

APA

Schütz, C., Inselmann, S., Saussele, S., Dietz, C. T., Müller, M. C., Eigendorff, E., … Burchert, A. (2018, April 1). Erratum: Expression of the CTLA-4 ligand CD86 on plasmacytoid dendritic cells (pDC) predicts risk of disease recurrence after treatment discontinuation in CML (Leukemia, (2017), 31, 4, (829-836), 10.1038/leu.2017.9). Leukemia. Springer Nature. https://doi.org/10.1038/leu.2017.348

Erratum: Expression of the CTLA-4 ligand CD86 on plasmacytoid dendritic cells (pDC) predicts risk of disease recurrence after treatment discontinuation in CML (Leukemia, (2017), 31, 4, (829-836), 10.1038/leu.2017.9)

Abstract

Cite

Register to see more suggestions